Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lung Capacity01:47

Lung Capacity

56.4K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.4K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

3.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

6.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.1K
Pleura of the Lungs01:13

Pleura of the Lungs

7.7K
The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
7.7K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

15.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein Overexpressing, Nonsquamous, <i>EGFR</i> Wild-type Advanced NSCLC: Updated Analysis of the LUMINOSITY Trial.

JTO clinical and research reports·2026
Same author

Exploring Thoracic Radiotherapy in Metastatic NSCLC: A Retrospective Review in the Era of Immunotherapy and Targeted Therapies.

Clinical lung cancer·2026
Same author

[Thoracic oncology].

Deutsche medizinische Wochenschrift (1946)·2026
Same author

Is surgery with curative intent feasible in old and very old patients with non-small cell lung cancer? - Experience of a certified lung cancer center over one decade.

Langenbeck's archives of surgery·2026
Same author

Feasibility and safety of nintedanib in combination with nivolumab in pretreated patients with advanced or metastatic adenocarcinoma of the lung - An AIO phase Ib/II trial.

Lung cancer (Amsterdam, Netherlands)·2026
Same author

Lung Cancer Patients From Oncology and Thoracic Surgery Units Show Similar Acceptance of Telemedicine Services.

Interdisciplinary cardiovascular and thoracic surgery·2026
Same journal

[Treatment of Vocal Fold Paralysis].

Zentralblatt fur Chirurgie·2026
Same journal

Zentralblatt fur Chirurgie·2026
Same journal

Predictive Factors for Mediastinal Lymph Node Metastases in Patients with Non-small Cell Lung Cancer, as Detected by Video-assisted Mediastinoscopic Lymphadenectomy.

Zentralblatt fur Chirurgie·2026
Same journal

[Robotic Management of a Bile Leak After Cholecystectomy Caused by an Aberrant Bile Duct of the Hepatic Segments, Using a Combined Biliodigestive Anastomosis Incorporating the Cystic Duct Stump].

Zentralblatt fur Chirurgie·2026
Same journal

[Microvascular Reconstruction of the Laryngotracheal Junction].

Zentralblatt fur Chirurgie·2026
Same journal

[Evaluation of Multimodal Perioperative Care Pathway Supported by a Patient-facing Mobile App in Colorectal Surgery - First Clinical Experience and Patient Satisfaction].

Zentralblatt fur Chirurgie·2026
See all related articles

Related Experiment Video

Updated: Feb 13, 2026

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
09:45

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines

Published on: August 21, 2019

7.5K

[Small Cell Lung Cancer].

Niels Reinmuth, Hans Hoffmann

    Zentralblatt Fur Chirurgie
    |February 28, 2018
    PubMed
    Summary
    This summary is machine-generated.

    Small cell lung cancer (SCLC) progresses rapidly with early metastasis. While chemotherapy is effective, resistance develops, necessitating novel treatments like immune checkpoint inhibitors for better outcomes.

    More Related Videos

    Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
    05:17

    Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

    Published on: October 10, 2025

    429
    Instillation and Fixation Methods Useful in Mouse Lung Cancer Research
    06:57

    Instillation and Fixation Methods Useful in Mouse Lung Cancer Research

    Published on: August 31, 2015

    29.6K

    Related Experiment Videos

    Last Updated: Feb 13, 2026

    Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
    09:45

    Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines

    Published on: August 21, 2019

    7.5K
    Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
    05:17

    Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

    Published on: October 10, 2025

    429
    Instillation and Fixation Methods Useful in Mouse Lung Cancer Research
    06:57

    Instillation and Fixation Methods Useful in Mouse Lung Cancer Research

    Published on: August 31, 2015

    29.6K

    Area of Science:

    • Oncology
    • Pulmonology
    • Cancer Research

    Background:

    • Small cell lung cancer (SCLC) comprises approximately 14% of all lung cancer diagnoses.
    • SCLC is known for its aggressive nature, characterized by rapid progression, early metastasis, and a generally poor prognosis.
    • While surgery is an option for a small subset of early-stage patients, most present with advanced disease.

    Purpose of the Study:

    • To review the current treatment landscape for small cell lung cancer.
    • To highlight the challenges posed by treatment resistance and disease progression in SCLC.
    • To explore emerging therapeutic strategies for managing advanced SCLC.

    Main Methods:

    • Review of existing literature on small cell lung cancer epidemiology and treatment.
    • Analysis of the efficacy and limitations of current standard therapies, including chemotherapy and radiotherapy.
    • Examination of preliminary data from early clinical trials investigating novel agents.

    Main Results:

    • Platinum doublet chemotherapy initially shows effectiveness in most SCLC patients.
    • However, virtually all patients with metastatic SCLC eventually develop tumor progression.
    • Limited effective treatment options exist for patients with progressive or recurrent SCLC.

    Conclusions:

    • Novel therapeutic approaches are crucial for improving outcomes in small cell lung cancer.
    • Immune checkpoint inhibitors and antibody drug conjugates like rovalpituzumab tesirine show promise.
    • These innovative treatments may offer expanded options for patients with advanced SCLC in the future.